Article Per Year (5 Year)
p-Index From 2020 - 2025
0
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran
Syafitri Sudiro, Giardani
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Wilson’s Disease: Current Therapies, Its Controversies, and Potential New Therapeutics Rima Sutiono, Dias; Syafitri Sudiro, Giardani
Cermin Dunia Kedokteran Vol 45, No 1 (2018): Suplemen
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (148.793 KB) | DOI: 10.55175/cdk.v45i1.164

Abstract

Wilson’s Disease is a rare genetic disorder with the prevalence of 1 in every 30,000 people, due to the mutation of the ATP7B gene responsible for copper metabolism. The mutation causes copper accumulation in the body, especially in the liver and brain, which leads to hepatic, neurological, psychological symptoms. These symptoms, if not treated properly, may lead to death after several years. Several treatments including low copper diet, zinc salts treatment, chelating agents (penicillamine, trientine, ammonium tetrahimiolybdate), and liver transplant are currently available. Severe neurological deterioration and other side effects need new, more efficient, and safer therapeutics. Several new therapeutic agents including 4-phenylbutyrate, curcumin, chelating polymeric beads, and long term metabolic correction have been tested in vitro and in vivo. These new therapeutics may be a potential new treatment with less side effect and greater efficacy for Wilson’s Disease patients.
Co-Authors Rima Sutiono, Dias